Telaprevir and anaemia: What we learned from the first three patients

Author： Sarikaya Murat   Doğan Zeynal   Ergül Bilal   Filik Levent  

Publisher： Informa Healthcare

ISSN： 0036-5548

Source： Scandinavian Journal of Infectious Diseases, Vol.45, Iss.7, 2013-07, pp. : 575-575

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

What We Have Learned From a Decade of ED Crowding Research

By  

ACADEMIC EMERGENCY MEDICINE, Vol. 22, Iss. 8, 2015-08 ,pp. : 985-987

John Wiley & Sons Inc

Access to resources Recommend Favorite

Antibiotic resistance: what have we learned and where do we go from here?

By Blondeau Joseph  

Therapy, Vol. 3, Iss. 6, 2006-11 ,pp. : 751-753

Future Medicine

Access to resources Recommend Favorite

Infant body composition in the PEA POD® era: what have we learned and where do we go from here?

By  

Journal of Developmental Origins of Health and Disease, Vol. 4, Iss. 2, 2012-11 ,pp. : 116-120

Cambridge University Press

Access to resources Recommend Favorite

Alveolar fluid clearance in acute lung injury: what have we learned from animal models and clinical studies?

By Morty Rory   Eickelberg Oliver   Seeger Werner  

Intensive Care Medicine, Vol. 33, Iss. 7, 2007-07 ,pp. : 1229-1240

Springer Publishing Company

Access to resources Recommend Favorite

Men's health promotion interventions: what have we learned from previous programmes?

By Robertson Steve   Witty Karl   Zwolinsky Steve   Day Rhiannon  

Community Practitioner, Vol. 86, Iss. 11, 2013-11 ,pp. : 38-41

Community Practitioner

Access to resources Recommend Favorite